GlassScriptPhysician profile
Amye W Groves
NPI 1295030393
$4,471.62
in general payments reported to CMS, 2019-2025
42 companies · $753 in 2025
The $753 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,059 · 2022: $387 · 2023: $1,253 · 2024: $1,020 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,025.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.70 | 2021-2025 | |
| Exact Sciences Corporation | $383.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $360.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $331.13 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Otsuka America Pharmaceutical, INC. | $272.17 | 2022-2025 | Rexulti |
| Glaxosmithkline, LLC. | $241.54 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Sumitomo Pharma America, INC. | $215.29 | 2023-2025 | Gemtesa, Aptiom |
| Novo Nordisk INC | $156.20 | 2021-2025 | Ozempic |
| Lundbeck LLC | $155.32 | 2023-2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $145.87 | 2021-2022 | |
| Amgen INC. | $137.51 | 2021-2024 | Repatha, Otezla, Prolia |
| Astellas Pharma US INC | $134.41 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $120.81 | 2021-2024 | |
| Xeris Pharmaceuticals, INC. | $119.20 | 2023 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.87 | 2021-2025 | Xifaxan |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amye Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.